1 Progress and issues for computationally guided lead discovery and optimization 1
William L. Jorgensen
PART I. STRUCTURAL BIOLOGY
2 X-ray crystallography in the service of structure-based drug design 17
Gregory A. Petsko and Dagmar Ringe
3 Fragment-based structure-guided drug discovery: strategy, process, and lessons
from human protein kinases 30
Stephen K. Burley, Gavin Hirst, Paul Sprengeler, and Siegfried Reich
4 NMR in fragment-based drug discovery 41
Christopher A. Lepre, Peter J. Connolly, and Jonathan M. Moore
PART II. COMPUTATIONAL CHEMISTRY METHODOLOGY
5 Free-energy calculations in structure-based drug design 61
Michael R. Shirts, David L. Mobley, and Scott P. Brown
6 Studies of drug resistance and the dynamic behavior of HIV-1 protease through
molecular dynamics simulations 87
Fangyu Ding and Carlos Simmerling
7 Docking: a domesday report 98
Martha S. Head
8 The role of quantum mechanics in structure-based drug design 120
Kenneth M. Merz, Jr.
9 Pharmacophore methods 137
Steven L. Dixon
10 QSAR in drug discovery 151
Alexander Tropsha
11 Predicting ADME properties in drug discovery 165
William J. Egan
PART III: APPLICATIONS TO DRUG DISCOVERY
12 Computer-aided drug design: a practical guide to protein-structure-based modeling 181
Charles H. Reynolds
13 Structure-based drug design case study: p38 197
Arthur M. Doweyko
14 Structure-based design of novel P2-P4 macrocyclic inhibitors of hepatitis
C NS3/4A protease 209
M. Katharine Holloway and Nigel J. Liverton
15 Purine nucleoside phosphorylases as targets for transition-state analog design 215
Andrew S. Murkin and Vern L. Schramm
没人需要这本书吗??
顶一下,感谢分享!
顶一下,感谢分享!
顶一下,感谢分享!
顶一下,感谢分享!
Contributors pagevii
Preface ix
1 Progress and issues for computationally guided lead discovery and optimization 1
William L. Jorgensen
PART I. STRUCTURAL BIOLOGY
2 X-ray crystallography in the service of structure-based drug design 17
Gregory A. Petsko and Dagmar Ringe
3 Fragment-based structure-guided drug discovery: strategy, process, and lessons
from human protein kinases 30
Stephen K. Burley, Gavin Hirst, Paul Sprengeler, and Siegfried Reich
4 NMR in fragment-based drug discovery 41
Christopher A. Lepre, Peter J. Connolly, and Jonathan M. Moore
PART II. COMPUTATIONAL CHEMISTRY METHODOLOGY
5 Free-energy calculations in structure-based drug design 61
Michael R. Shirts, David L. Mobley, and Scott P. Brown
6 Studies of drug resistance and the dynamic behavior of HIV-1 protease through
molecular dynamics simulations 87
Fangyu Ding and Carlos Simmerling
7 Docking: a domesday report 98
Martha S. Head
8 The role of quantum mechanics in structure-based drug design 120
Kenneth M. Merz, Jr.
9 Pharmacophore methods 137
Steven L. Dixon
10 QSAR in drug discovery 151
Alexander Tropsha
11 Predicting ADME properties in drug discovery 165
William J. Egan
PART III: APPLICATIONS TO DRUG DISCOVERY
12 Computer-aided drug design: a practical guide to protein-structure-based modeling 181
Charles H. Reynolds
13 Structure-based drug design case study: p38 197
Arthur M. Doweyko
14 Structure-based design of novel P2-P4 macrocyclic inhibitors of hepatitis
C NS3/4A protease 209
M. Katharine Holloway and Nigel J. Liverton
15 Purine nucleoside phosphorylases as targets for transition-state analog design 215
Andrew S. Murkin and Vern L. Schramm
16 GPCR 3D modeling 248
Frank U. Axe
17 Structure-based design of potent glycogen phosphorylase inhibitors 257
Qiaolin Deng,
顶一下,感谢分享!